Home » Thought Leadership

Thought Leadership

Read our insights and commentary about pharmaceutical industry news and healthcare innovation globally. Subscribe to our monthly newsletter to keep up to date with our thought leadership, news, and updates.

Showing 5 of 133 posts
Non-traditional Players Attempting Healthcare PART I
September 8, 2021 | Blogs

Part I: Non-Traditional Players Attempting Entry Into the Healthcare Sector

In part one of this two-part series about non-traditional players in the healthcare sector, CBPartners explores the increasingly attractive market despite the risk of an expensive failed venture by analyzing the success and failures of four non-traditional players.

September 1, 2021 | Blogs

Exploring the Impact of COVID-Driven Trends on the US Healthcare Landscape

CBPartners reviews the COVID-driven changes to patients, providers, payers, clinical research, and pharmaceutical distribution within the US.

Image of Verily's office
August 30, 2021 | Blogs

Verily to Acquire SignalPath, Expanding the Company’s Clinical Research Capabilities

Verily recently announced its first major acquisition, a software platform known as SignalPath. The acquisition would fold SignalPath into Baseline, Verily’s clinical research platform.

Oncology Market Access Opportunities 2020 NRDL
August 26, 2021 | Blogs

What Market Access Opportunities Exist for Oncology Products in China? An Analysis of Oncology Product Inclusion in the 2020 NRDL

Fourteen oncology drugs were successfully negotiated and included in the 2020 NRDL. As the new prices became effective from March 01, 2021, several key features and trends have been observed.

Regulators and HTA Bodies
August 24, 2021 | Blogs, Infographics

Drug Assessment Uncertainties: HTA Bodies vs. Regulators

A recent study of the review of new medicines by regulatory and HTA bodies has revealed areas of misalignment in their processes, highlighting unique challenges in the pathway to patient access.